| Předmět: |
|
| Zdroj: |
Respiratory Therapeutics Week; 6/2/2023, p425-425, 1p |
| Abstrakt: |
A 2-year follow-up of the study population after the initial prospective and simultaneous analysis of lymphocyte activation markers expression in the blood, as well as bronchoalveolar lavage fluid (BALF) and lung biopsy tissue of patients with newly diagnosed pulmonary sarcoidosis, was performed. Keywords: Biomarkers; Blood Cells; Dermatology; Diagnostics and Screening; Health and Medicine; Hemic and Immune Systems; Immunology; Leukocytes; Lung Diseases and Conditions; Lymphatic Diseases and Conditions; Lymphocyte Subsets; Lymphocytes; Lymphoproliferative Diseases and Conditions; Lymphoproliferative Disorders; Mononuclear Leukocytes; Pulmonary Sarcoidosis; Sarcoidosis EN Biomarkers Blood Cells Dermatology Diagnostics and Screening Health and Medicine Hemic and Immune Systems Immunology Leukocytes Lung Diseases and Conditions Lymphatic Diseases and Conditions Lymphocyte Subsets Lymphocytes Lymphoproliferative Diseases and Conditions Lymphoproliferative Disorders Mononuclear Leukocytes Pulmonary Sarcoidosis Sarcoidosis 425 425 1 05/29/23 20230602 NES 230602 2023 JUN 3 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- A new study on pulmonary sarcoidosis is now available. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
